Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-10

FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lamotrigine from Zydus Pharmaceuticals USA Inc., indicating an update to its labeling/indication. The document c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)